nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Methotrexate—urinary bladder cancer	0.0269	1	CbGbCtD
Penicillamine—Extravasation—Doxorubicin—urinary bladder cancer	0.00247	0.00254	CcSEcCtD
Penicillamine—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00245	0.00252	CcSEcCtD
Penicillamine—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00244	0.00251	CcSEcCtD
Penicillamine—Nausea—Mitomycin—urinary bladder cancer	0.00244	0.0025	CcSEcCtD
Penicillamine—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00241	0.00248	CcSEcCtD
Penicillamine—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.00241	0.00248	CcSEcCtD
Penicillamine—Haemorrhage—Fluorouracil—urinary bladder cancer	0.0024	0.00247	CcSEcCtD
Penicillamine—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.0024	0.00246	CcSEcCtD
Penicillamine—Urethral disorder—Gemcitabine—urinary bladder cancer	0.00239	0.00246	CcSEcCtD
Penicillamine—Glossitis—Doxorubicin—urinary bladder cancer	0.00234	0.0024	CcSEcCtD
Penicillamine—Anaemia—Thiotepa—urinary bladder cancer	0.00233	0.0024	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00233	0.0024	CcSEcCtD
Penicillamine—Agitation—Thiotepa—urinary bladder cancer	0.00232	0.00239	CcSEcCtD
Penicillamine—Renal failure—Etoposide—urinary bladder cancer	0.00228	0.00235	CcSEcCtD
Penicillamine—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00228	0.00234	CcSEcCtD
Penicillamine—Stomatitis—Etoposide—urinary bladder cancer	0.00226	0.00233	CcSEcCtD
Penicillamine—Leukopenia—Thiotepa—urinary bladder cancer	0.00226	0.00232	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—urinary bladder cancer	0.00225	0.00231	CcSEcCtD
Penicillamine—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.00225	0.00231	CcSEcCtD
Penicillamine—Urethral disorder—Cisplatin—urinary bladder cancer	0.00223	0.00229	CcSEcCtD
Penicillamine—Angiopathy—Gemcitabine—urinary bladder cancer	0.00221	0.00228	CcSEcCtD
Penicillamine—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.0022	0.00226	CcSEcCtD
Penicillamine—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00218	0.00224	CcSEcCtD
Penicillamine—Neuropathy—Epirubicin—urinary bladder cancer	0.00218	0.00224	CcSEcCtD
Penicillamine—Agranulocytosis—Etoposide—urinary bladder cancer	0.00217	0.00223	CcSEcCtD
Penicillamine—Alopecia—Gemcitabine—urinary bladder cancer	0.00216	0.00222	CcSEcCtD
Penicillamine—Arthralgia—Thiotepa—urinary bladder cancer	0.00215	0.00221	CcSEcCtD
Penicillamine—Anxiety—Thiotepa—urinary bladder cancer	0.00214	0.0022	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00214	0.00219	CcSEcCtD
Penicillamine—Tinnitus—Cisplatin—urinary bladder cancer	0.00212	0.00218	CcSEcCtD
Penicillamine—Alopecia—Fluorouracil—urinary bladder cancer	0.00212	0.00218	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—urinary bladder cancer	0.00212	0.00217	CcSEcCtD
Penicillamine—Mouth ulceration—Epirubicin—urinary bladder cancer	0.0021	0.00216	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.00208	0.00214	CcSEcCtD
Penicillamine—Urinary tract disorder—Etoposide—urinary bladder cancer	0.00206	0.00212	CcSEcCtD
Penicillamine—Urethral disorder—Etoposide—urinary bladder cancer	0.00204	0.0021	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—urinary bladder cancer	0.00202	0.00208	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00202	0.00208	CcSEcCtD
Penicillamine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00202	0.00207	CcSEcCtD
Penicillamine—Alopecia—Cisplatin—urinary bladder cancer	0.00201	0.00207	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—urinary bladder cancer	0.00201	0.00206	CcSEcCtD
Penicillamine—Skin disorder—Thiotepa—urinary bladder cancer	0.002	0.00206	CcSEcCtD
Penicillamine—Lymphadenopathy—Epirubicin—urinary bladder cancer	0.00198	0.00203	CcSEcCtD
Penicillamine—Anorexia—Thiotepa—urinary bladder cancer	0.00197	0.00202	CcSEcCtD
Penicillamine—Anaemia—Gemcitabine—urinary bladder cancer	0.00196	0.00202	CcSEcCtD
Penicillamine—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.00195	0.00201	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—urinary bladder cancer	0.00195	0.002	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Epirubicin—urinary bladder cancer	0.00194	0.002	CcSEcCtD
Penicillamine—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00193	0.00199	CcSEcCtD
Penicillamine—Anaemia—Fluorouracil—urinary bladder cancer	0.00193	0.00198	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.00191	0.00197	CcSEcCtD
Penicillamine—Leukopenia—Gemcitabine—urinary bladder cancer	0.0019	0.00195	CcSEcCtD
Penicillamine—Angiopathy—Etoposide—urinary bladder cancer	0.00189	0.00194	CcSEcCtD
Penicillamine—Hepatic failure—Epirubicin—urinary bladder cancer	0.00188	0.00193	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00188	0.00193	CcSEcCtD
Penicillamine—Leukopenia—Fluorouracil—urinary bladder cancer	0.00187	0.00192	CcSEcCtD
Penicillamine—Alopecia—Etoposide—urinary bladder cancer	0.00184	0.00189	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—urinary bladder cancer	0.00183	0.00188	CcSEcCtD
Penicillamine—Anaemia—Cisplatin—urinary bladder cancer	0.00183	0.00188	CcSEcCtD
Penicillamine—Arthralgia—Gemcitabine—urinary bladder cancer	0.00181	0.00186	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.00181	0.00186	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—urinary bladder cancer	0.0018	0.00185	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.0018	0.00185	CcSEcCtD
Penicillamine—Decreased appetite—Thiotepa—urinary bladder cancer	0.00179	0.00184	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00179	0.00184	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.00179	0.00184	CcSEcCtD
Penicillamine—Dysgeusia—Etoposide—urinary bladder cancer	0.00178	0.00183	CcSEcCtD
Penicillamine—Leukopenia—Cisplatin—urinary bladder cancer	0.00177	0.00182	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—urinary bladder cancer	0.00174	0.00179	CcSEcCtD
Penicillamine—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00173	0.00178	CcSEcCtD
Penicillamine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.0017	0.00174	CcSEcCtD
Penicillamine—Skin disorder—Gemcitabine—urinary bladder cancer	0.00168	0.00173	CcSEcCtD
Penicillamine—Anxiety—Cisplatin—urinary bladder cancer	0.00168	0.00173	CcSEcCtD
Penicillamine—Anaemia—Etoposide—urinary bladder cancer	0.00168	0.00172	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00167	0.00172	CcSEcCtD
Penicillamine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00167	0.00172	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00166	0.0017	CcSEcCtD
Penicillamine—Anorexia—Gemcitabine—urinary bladder cancer	0.00165	0.0017	CcSEcCtD
Penicillamine—Urticaria—Thiotepa—urinary bladder cancer	0.00164	0.00168	CcSEcCtD
Penicillamine—Body temperature increased—Thiotepa—urinary bladder cancer	0.00163	0.00167	CcSEcCtD
Penicillamine—Anorexia—Fluorouracil—urinary bladder cancer	0.00163	0.00167	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00163	0.00167	CcSEcCtD
Penicillamine—Leukopenia—Etoposide—urinary bladder cancer	0.00162	0.00167	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.0016	0.00165	CcSEcCtD
Penicillamine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00158	0.00163	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00158	0.00162	CcSEcCtD
Penicillamine—Skin disorder—Cisplatin—urinary bladder cancer	0.00157	0.00161	CcSEcCtD
Penicillamine—Asthma—Methotrexate—urinary bladder cancer	0.00156	0.0016	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00155	0.0016	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—urinary bladder cancer	0.00154	0.00159	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00154	0.00159	CcSEcCtD
Penicillamine—Anorexia—Cisplatin—urinary bladder cancer	0.00154	0.00158	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00153	0.00158	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—urinary bladder cancer	0.00153	0.00157	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00152	0.00156	CcSEcCtD
Penicillamine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00152	0.00156	CcSEcCtD
Penicillamine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00151	0.00155	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—urinary bladder cancer	0.00149	0.00153	CcSEcCtD
Penicillamine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00148	0.00152	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—urinary bladder cancer	0.00148	0.00152	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00147	0.00151	CcSEcCtD
Penicillamine—Asthma—Epirubicin—urinary bladder cancer	0.00146	0.0015	CcSEcCtD
Penicillamine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00145	0.00149	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—urinary bladder cancer	0.00145	0.00149	CcSEcCtD
Penicillamine—Skin disorder—Etoposide—urinary bladder cancer	0.00144	0.00148	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—urinary bladder cancer	0.00143	0.00147	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00143	0.00147	CcSEcCtD
Penicillamine—Anorexia—Etoposide—urinary bladder cancer	0.00141	0.00145	CcSEcCtD
Penicillamine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00141	0.00145	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00141	0.00145	CcSEcCtD
Penicillamine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00141	0.00144	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00138	0.00142	CcSEcCtD
Penicillamine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00137	0.00141	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—urinary bladder cancer	0.00136	0.00139	CcSEcCtD
Penicillamine—Urticaria—Fluorouracil—urinary bladder cancer	0.00135	0.00139	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—urinary bladder cancer	0.00135	0.00139	CcSEcCtD
Penicillamine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00135	0.00139	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—urinary bladder cancer	0.00133	0.00136	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00132	0.00136	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00132	0.00135	CcSEcCtD
Penicillamine—Vomiting—Thiotepa—urinary bladder cancer	0.00131	0.00135	CcSEcCtD
Penicillamine—Rash—Thiotepa—urinary bladder cancer	0.0013	0.00134	CcSEcCtD
Penicillamine—Dermatitis—Thiotepa—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Penicillamine—Decreased appetite—Etoposide—urinary bladder cancer	0.00129	0.00132	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00128	0.00132	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Penicillamine—Body temperature increased—Cisplatin—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—urinary bladder cancer	0.00127	0.0013	CcSEcCtD
Penicillamine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00126	0.00129	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—urinary bladder cancer	0.00125	0.00129	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—urinary bladder cancer	0.00124	0.00128	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00123	0.00127	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00123	0.00127	CcSEcCtD
Penicillamine—Nausea—Thiotepa—urinary bladder cancer	0.00122	0.00126	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—urinary bladder cancer	0.00122	0.00126	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00121	0.00125	CcSEcCtD
Penicillamine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Penicillamine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—urinary bladder cancer	0.00118	0.00122	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Penicillamine—Urticaria—Etoposide—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—urinary bladder cancer	0.00117	0.00121	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—urinary bladder cancer	0.00117	0.00121	CcSEcCtD
Penicillamine—Body temperature increased—Etoposide—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Penicillamine—Haemorrhage—Epirubicin—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Penicillamine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—urinary bladder cancer	0.00116	0.0012	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00115	0.00119	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—urinary bladder cancer	0.00115	0.00118	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—urinary bladder cancer	0.00115	0.00118	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00114	0.00117	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—urinary bladder cancer	0.00113	0.00116	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Penicillamine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00111	0.00114	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Penicillamine—Vomiting—Gemcitabine—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Penicillamine—Rash—Gemcitabine—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Penicillamine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Penicillamine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Penicillamine—Vomiting—Fluorouracil—urinary bladder cancer	0.00108	0.00111	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00108	0.00111	CcSEcCtD
Penicillamine—Rash—Fluorouracil—urinary bladder cancer	0.00108	0.0011	CcSEcCtD
Penicillamine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00107	0.0011	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00107	0.0011	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—urinary bladder cancer	0.00106	0.00109	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—urinary bladder cancer	0.00106	0.00109	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00106	0.00109	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Penicillamine—Nausea—Gemcitabine—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Penicillamine—Vomiting—Cisplatin—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Penicillamine—Rash—Cisplatin—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Penicillamine—Dermatitis—Cisplatin—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Penicillamine—Diarrhoea—Etoposide—urinary bladder cancer	0.00101	0.00104	CcSEcCtD
Penicillamine—Nausea—Fluorouracil—urinary bladder cancer	0.00101	0.00104	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—urinary bladder cancer	0.00101	0.00104	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—urinary bladder cancer	0.001	0.00103	CcSEcCtD
Penicillamine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000996	0.00102	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000981	0.00101	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—urinary bladder cancer	0.000973	0.001	CcSEcCtD
Penicillamine—Nausea—Cisplatin—urinary bladder cancer	0.00096	0.000987	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—urinary bladder cancer	0.000955	0.000982	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000947	0.000973	CcSEcCtD
Penicillamine—Vomiting—Etoposide—urinary bladder cancer	0.000942	0.000968	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—urinary bladder cancer	0.00094	0.000966	CcSEcCtD
Penicillamine—Agitation—Epirubicin—urinary bladder cancer	0.000935	0.000961	CcSEcCtD
Penicillamine—Rash—Etoposide—urinary bladder cancer	0.000934	0.00096	CcSEcCtD
Penicillamine—Dermatitis—Etoposide—urinary bladder cancer	0.000933	0.000959	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—urinary bladder cancer	0.000925	0.000951	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000922	0.000947	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000919	0.000944	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—urinary bladder cancer	0.00091	0.000936	CcSEcCtD
Penicillamine—Nausea—Etoposide—urinary bladder cancer	0.00088	0.000904	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—urinary bladder cancer	0.00087	0.000894	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000869	0.000893	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—urinary bladder cancer	0.000866	0.00089	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—urinary bladder cancer	0.000865	0.000889	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—urinary bladder cancer	0.000863	0.000887	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—urinary bladder cancer	0.000862	0.000885	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00086	0.000884	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—urinary bladder cancer	0.000846	0.000869	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000842	0.000866	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000813	0.000835	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000808	0.000831	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—urinary bladder cancer	0.000806	0.000829	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000801	0.000823	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—urinary bladder cancer	0.000798	0.000821	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000796	0.000818	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—urinary bladder cancer	0.000791	0.000813	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000771	0.000792	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000756	0.000777	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000752	0.000773	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000746	0.000767	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—urinary bladder cancer	0.000732	0.000752	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000722	0.000742	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—urinary bladder cancer	0.000705	0.000724	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000701	0.000721	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.0007	0.000719	CcSEcCtD
Penicillamine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000668	0.000686	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—urinary bladder cancer	0.000659	0.000678	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000656	0.000674	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000654	0.000672	CcSEcCtD
Penicillamine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000612	0.000629	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—urinary bladder cancer	0.00061	0.000627	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000607	0.000624	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000607	0.000624	CcSEcCtD
Penicillamine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000568	0.000584	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000566	0.000582	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—urinary bladder cancer	0.000564	0.00058	CcSEcCtD
Penicillamine—Rash—Methotrexate—urinary bladder cancer	0.000559	0.000575	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—urinary bladder cancer	0.000559	0.000574	CcSEcCtD
Penicillamine—Vomiting—Epirubicin—urinary bladder cancer	0.000528	0.000542	CcSEcCtD
Penicillamine—Nausea—Methotrexate—urinary bladder cancer	0.000527	0.000541	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000526	0.00054	CcSEcCtD
Penicillamine—Rash—Epirubicin—urinary bladder cancer	0.000523	0.000538	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—urinary bladder cancer	0.000523	0.000537	CcSEcCtD
Penicillamine—Nausea—Epirubicin—urinary bladder cancer	0.000493	0.000507	CcSEcCtD
Penicillamine—Vomiting—Doxorubicin—urinary bladder cancer	0.000488	0.000502	CcSEcCtD
Penicillamine—Rash—Doxorubicin—urinary bladder cancer	0.000484	0.000498	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000484	0.000497	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—urinary bladder cancer	0.000456	0.000469	CcSEcCtD
